Sign in to view content

Baseline Factors Associated With 1-Year Outcomes in Phase III Comparison of SB11 (Approved Ranibizumab Biosimilar) With Reference Ranibizumab in nAMD

Neil M. Bressler, MD

Video
Published 2022

Related

Episode 19: LEAD Trial for Use of Nanopulse Laser for Dry AMD with Dr. Robyn Guymer
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018
Episode 13: Long-Term Treatment of Wet AMD by 50+ Anti-VEGF Injections with Dr. Sean Adrean
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018
CNV Due to Angioid Streaks
Simon Kelly, MB, FRCSEd, FRCOphth, FEBO, DHC
Retina Image Bank: Images of the Week
2014

Category: AMD-Neovascular

See more